176 related articles for article (PubMed ID: 28060750)
21. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1.
Choi DW; Seo YM; Kim EA; Sung KS; Ahn JW; Park SJ; Lee SR; Choi CY
J Biol Chem; 2008 Feb; 283(8):4682-9. PubMed ID: 18093972
[TBL] [Abstract][Full Text] [Related]
22. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.
Gresko E; Roscic A; Ritterhoff S; Vichalkovski A; del Sal G; Schmitz ML
EMBO J; 2006 May; 25(9):1883-94. PubMed ID: 16601678
[TBL] [Abstract][Full Text] [Related]
23. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
24. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
25. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
[TBL] [Abstract][Full Text] [Related]
26. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).
van der Laden J; Soppa U; Becker W
Cell Commun Signal; 2015 Jan; 13():3. PubMed ID: 25630557
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.
Muschik D; Braspenning-Wesch I; Stockfleth E; Rösl F; Hofmann TG; Nindl I
PLoS One; 2011; 6(11):e27655. PubMed ID: 22110707
[TBL] [Abstract][Full Text] [Related]
28. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
Nardinocchi L; Puca R; Givol D; D'Orazi G
FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
[TBL] [Abstract][Full Text] [Related]
29. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
Rinaldo C; Prodosmo A; Mancini F; Iacovelli S; Sacchi A; Moretti F; Soddu S
Mol Cell; 2007 Mar; 25(5):739-50. PubMed ID: 17349959
[TBL] [Abstract][Full Text] [Related]
30. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
[TBL] [Abstract][Full Text] [Related]
31. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
[TBL] [Abstract][Full Text] [Related]
32. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
[TBL] [Abstract][Full Text] [Related]
33. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
Hofmann TG; Stollberg N; Schmitz ML; Will H
Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
[TBL] [Abstract][Full Text] [Related]
34. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
[TBL] [Abstract][Full Text] [Related]
35. Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis.
Zhang Q; Nottke A; Goodman RH
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2802-7. PubMed ID: 15708980
[TBL] [Abstract][Full Text] [Related]
36. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
[TBL] [Abstract][Full Text] [Related]
37. An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis.
Gatti V; Ferrara M; Virdia I; Matteoni S; Monteonofrio L; di Martino S; Diodoro MG; Di Rocco G; Rinaldo C; Soddu S
Cells; 2020 Feb; 9(2):. PubMed ID: 32093146
[TBL] [Abstract][Full Text] [Related]
38. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.
Li Q; Wang X; Wu X; Rui Y; Liu W; Wang J; Wang X; Liou YC; Ye Z; Lin SC
Cancer Res; 2007 Jan; 67(1):66-74. PubMed ID: 17210684
[TBL] [Abstract][Full Text] [Related]
39. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
Dauth I; Krüger J; Hofmann TG
Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
Ohtsu N; Nobuhisa I; Mochita M; Taga T
Exp Cell Res; 2007 Jan; 313(1):88-97. PubMed ID: 17064687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
